I recently purchased some products from Bioassets Development Corporation and I must say I'm impressed. The quality is great and the prices are reasonable. I would definitely recommend them to others.
Haven't used Bioassets development corporation yet?
Ask AI
What reviewers say about Bioassets development corporation
Customer reviews are generally positive, with many praising the quality of products, reasonable pricing, and excellent customer service. Some customers described their experience as average, noting that the products were decent but nothing exceptional.
What does Bioassets development corporation do?
BioAssets Development Corporation is a biopharmaceutical company that develops spine indications for biologic drugs, focusing on tumor necrosis factor alpha (TNF) inhibitor therapies to treat conditions such as sciatica, rheumatoid arthritis, Crohn's disease, and psoriasis. It was founded in 2005 and operates as a subsidiary of Cephalon Inc. since November 2010.
Where is Bioassets development corporation located?
BioAssets Development Corporation is based in Wellesley, Massachusetts, according to the information on file.
Post your question publicly β other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
10 Reviews
π I had a wonderful experience with Bioassets Development Corporation. The quality of their products was excellent and the customer service was superb. I will definitely be a loyal customer!
I have had a mixed experience with Bioassets Development Corporation. While their customer service was excellent, I found their products to be average in quality. The prices were reasonable though, which was a plus. Overall, I would say it's an average company.
π I'm very satisfied with my experience with Bioassets Development Corporation. The customer service was top-notch and their products exceeded my expectations. I will definitely be a repeat customer!
π I had an excellent experience with Bioassets Development Corporation. Their customer service was outstanding and their products surpassed my expectations. I will definitely be purchasing from them again!
I recently had an average experience with Bioassets Development Corporation. The products I purchased were okay, but nothing extraordinary. The customer service was decent, but not exceptional.
My recent purchase from Bioassets Development Corporation was great. The products were of high quality and reasonably priced. I would highly recommend them to everyone.
I had an average experience with Bioassets Development Corporation. The products were of decent quality, but nothing exceptional. The customer service was satisfactory though.
I bought a few items from a website recently and my experience was just average. The quality of the products was decent, but nothing exceptional. The prices were reasonable though and the customer service was satisfactory.
The product I purchased from Bioassets Development Corporation was of great quality and reasonably priced. I'm very satisfied with my purchase and would recommend them to others.
Questions & Answers
No questions yet β be the first to ask.
Sign in to post
Your text is saved β you'll come right back to post.
or with email
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Bioassets development corporation
BioAssets Development Corporation, a biopharmaceutical company, develops spine indications for biologic drugs. It focuses on the development of a tumor necrosis factor alpha (TNF) inhibitor therapy to treat the underlying cause of pain in sciatica. It markets tumor necrosis factor alpha (TNF) inhibitors, which include monoclonal antibodies, infliximab or adalimumab, TNF-receptor fusion protein etanercept, and biologic drugs for the treatment of inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. The companyβs lead program also tests the potential of TNF inhibitors to treat pain and prevent nerve damage in patients with spinal disorders by treating the neuro-inflammatory disease mechanism. BioAssets Development Corporation was founded in 2005 and is based in Wellesley, Massachusetts. As of November 19, 2010, BioAssets Development Corporation operates as a subsidiary of Cephalon Inc.
- Website
- biodevco.com
- Address
- 888 worcester street
- Categories
- Biotechnology
